SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000816284-18-000016
Filing Date
2018-07-26
Accepted
2018-07-26 16:57:06
Documents
104
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a2018063010q.htm 10-Q 2888138
2 EXHIBIT 31.1 ex311certificationoftheceo.htm EX-31.1 10310
3 EXHIBIT 31.2 ex312certificationofthecfo.htm EX-31.2 11167
4 EXHIBIT 32.1 ex321certificationoftheceo.htm EX-32.1 6899
5 EXHIBIT 32.2 ex322certificationofthecfo.htm EX-32.2 8300
  Complete submission text file 0000816284-18-000016.txt   15001480

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT celg-20180630.xml EX-101.INS 4182301
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT celg-20180630.xsd EX-101.SCH 79914
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT celg-20180630_cal.xml EX-101.CAL 120306
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT celg-20180630_def.xml EX-101.DEF 517153
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT celg-20180630_lab.xml EX-101.LAB 957693
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT celg-20180630_pre.xml EX-101.PRE 682810
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Filer) CIK: 0000816284 (see all company filings)

IRS No.: 222711928 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34912 | Film No.: 18972348
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1